A family of customised inhalers

Iconovo

vision

Replacing injections with inhalation

Icovono is a well-established Swedish company that offers innovative inhalation platforms for generic drug and pharmaceutical companies worldwide.

We’ve been working with Icovono since its start in 2013, contributing to various projects, including an FDA-approved product family that ensures a safe, effective, and user-friendly medical experience. Our support also includes providing advisory services on technical and mechanical solutions.

USER RESEARCH

Listening, testing, creating - bringing ideas to life

In medical devices, there’s no room for guesswork. Every dose must be delivered safely, effectively, and without error. That’s why our focus is on creating intuitive, fail-safe products right from the start.

Consider inhalers. If users don’t understand how to use them, the medication is wasted, along with the treatment opportunity. Our goal is to prevent that from happening. User testing- and research guide every step of our design process, from shaping the product to helping customers make strategic business choices. Through form, touch and clear visual communication, we create experiences that feel natural and require no explanation.

We understand the long road to market – regulatory approval for medical devices can take up to eight years. That's why we design for longevity: modern, yet timeless - grounded in deep user insights that help us make smart decisions along the way.

This is also where we benefit from user interviews: with deep, ongoing insight from real users, we build a reliable backlog of data to support well-rooted decisions throughout the product lifecycle.

result

Customizable family of inhalers

In our long-term collaboration with Iconovo, we’ve developed a family of inhalers designed for ease of use and consistent reliability. The inhalers are customizable, allowing Iconovo's customers to create tailored solutions. Their internal geometry is precisely adapted to match specific powder formulations, ensuring optimal aerodynamic performance and accurate lung dose delivery.

product

ICOone: injection free treatment

Inhalation-based drug delivery is gaining traction, not just for respiratory treatments, but also for systemic medications. Vaccines and GLP-1 treatments for weight loss, for example, can now be administered via inhalation instead of injections.

ICOone is ideal for treatments that require only a few doses to achieve full effectiveness. It offers key advantages, particularly when delivering vaccines in powder form. By using ICOone for vaccine distribution, we eliminate the need for trained medical personnel, syringes, needles, and handling of used needles. Moreover, ICOone removes the need for cold chain logistics and cold storage, increasing shelf life and simplifying the process, making it more cost-effective.

We’re thrilled to be part of this exciting collaboration and look forward to its continued success.

"Active collaboration with Zenit over the years have helped establish Iconovo as a globally recognized provider of high quality inhalation products. It’s all about having a great customer offer and design is important. Smart Nordic industrial design becomes a tangible differentiating feature that gives us that extra needed edge

- JOHAN WÄBORG, CEO ICONOVO